Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 4ii5 | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 1.000 | |
| 4eoo | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.547 | |
| 4i3z | ADP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.541 | |
| 1qmz | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.522 | |
| 3my5 | RFZ | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.462 | |
| 4qny | ANP | Mitogen activated protein kinase, putative | / | 0.456 | |
| 2uzb | C75 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.451 | |
| 4bcm | T7Z | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.449 | |
| 1j1c | ADP | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.443 | |
| 2cjm | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.443 |